Cura Therapeutics
CA - BerkeleyBiotechnology
Focus: Cura Therapeutics is a Berkeley-based biotech company focused on immunotherapies for neurological disorders. The company operates at an early-stage with limited public visibility on scale and development portfolio.
Profile data last refreshed 15h ago · AI intelligence enriched 1w ago
Open Jobs
5+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Cura Therapeutics?
AI assessmentCura represents a high-risk, high-reward early-stage bet for scientists or immunology experts seeking founding-team ownership, but insufficient public data and no disclosed pipeline make due diligence difficult.
Why Work Here
- Early-stage immunotherapy platform in high-value neurology space offers ground-floor opportunity to shape therapeutic strategy and company culture
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cura Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.